Skip to main content
. 2013 Dec 30;2013:618670. doi: 10.1155/2013/618670

Table 2.

The clinical data of included studies on CBDC patients with or without associated PBM.

First author
(year)
With PBM Without PBM
Number of patients Age at diagnosis Incidence of CDC Number of patients Age at diagnosis Incidence of CDC
Tashiro et al. [8] (2003) 153 24.3 ± 23.9 29/153 527 47.3 ± 19.3 61/527
Kamisawa et al. [13] (2010) 16 54.6 ± 14.2 5/16 91 58.8 ± 9.1 20/91
Matsumoto et al. [18] (2003) 39 63.0 ± 11.0 12/39 211 71.4 ± 10.4 24/211
Wang et al. [23] (1998) 11 NA 4/11 16 NA 3/16
Roukounakis et al. [10] (2007) 22 65.6 ± 9.8 7/22 4 68.0 ± 11.5 1/4
Ohuchida et al. [24] (2006) 55 30.0 ± 20.7 12/55 141 52.9 ± 16.8 11/141
Hasumi et al. [16] (2000) 63 53.2 ± 11.9 8/63 351 66.5 ± 18.4 44/351
Suda et al. [26] (1983) 27 NA NA 45 NA NA
Song et al. [25] (1999) 38 36.5 ± 14.1 7/38 291 49.2 ± 12.2 15/291
Seki et al. [27] (2005) 6 51.6 ± 13.3 4/6 32 50.9 ± 13.7 3/32

PBM: pancreaticobiliary maljunction; CBDC: common bile duct carcinoma; CDC: congenital dilatation of the common bile duct; NA: not available.